MERIDIAN BIOSCIENCE INC VIVO Income Statement

Meridian bioscience inc (VIVO)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Jun'09
NET REVENUES
204,003	196,955	201,014	203,268	206,565	212,768	213,571	210,168	208,571	206,245	200,771	198,072	198,597	195,731	196,082	196,152	193,691	193,977	194,830	194,454	193,462	192,051	188,832	191,102	190,998	188,129	188,686	183,207	178,014	177,988	172,712	169,691	167,828	161,648	158,836	153,913	147,718	137,806	143,000	145,701	0	0	0
COST OF SALES
84,694	82,762	82,689	81,943	81,537	82,509	82,874	80,997	80,216	78,982	76,479	75,262	74,024	71,063	68,870	68,295	68,412	69,749	72,948	73,964	74,061	73,578	71,589	71,386	69,893	67,874	67,642	65,496	63,517	64,686	63,664	64,074	64,277	61,688	59,916	57,769	55,189	51,093	54,304	55,016	0	0	0
GROSS PROFIT
119,309	114,193	118,325	121,325	125,028	130,259	130,697	129,171	128,355	127,263	124,292	122,810	124,573	124,668	127,212	127,857	125,279	124,228	121,882	120,490	119,401	118,473	117,243	119,716	121,105	120,255	121,044	117,711	114,497	113,302	109,048	105,108	103,042	99,451	98,411	96,144	92,529	86,713	88,696	90,685	0	0	0
OPERATING EXPENSES
Research and development
20,375	18,805	17,948	15,991	15,661	16,336	16,789	17,699	17,399	16,859	16,036	15,647	15,229	14,407	14,191	12,976	12,644	12,883	12,605	13,052	12,984	12,802	12,552	11,933	11,498	11,123	10,787	10,873	10,822	10,519	10,275	9,935	9,968	9,786	9,822	9,181	8,616	8,627	8,396	8,501	0	0	0
Selling and marketing
27,170	27,567	28,446	29,696	31,451	33,187	34,468	34,736	34,195	33,614	32,388	31,963	32,087	31,231	30,056	28,594	26,693	25,964	25,601	24,967	25,032	25,012	24,910	24,508	23,699	22,709	22,424	22,123	22,300	22,408	22,092	21,417	21,768	21,787	21,885	21,761	20,080	18,838	18,250	18,039	0	0	0
General and administrative
35,948	32,856	33,002	32,673	33,051	34,505	34,805	34,218	34,127	32,559	31,096	30,146	29,394	28,995	29,429	29,341	28,339	28,404	27,616	27,704	27,884	27,224	27,389	29,580	29,646	30,574	30,519	28,620	28,001	27,224	26,372	25,101	25,498	24,898	24,883	24,731	23,044	21,536	19,672	18,284	0	0	0
Acquisition-related costs
0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of contingent consideration obligation
0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition and restructuring costs
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restructuring costs
2,228	0	-	0	0	-	-	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selected legal costs
1,446	1,314	1,583	2,345	3,335	4,185	4,345	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill impairment charge
-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales and marketing leadership reorganization costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-
Plant consolidation costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,013	0	0	0	-	-	-	-	-	-	-	-	-
Bioline Group transaction costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0
Total operating expenses
89,811	86,651	85,626	87,365	88,797	96,185	99,113	95,890	99,505	91,905	86,910	85,340	77,666	76,791	75,834	72,113	68,878	67,251	65,822	65,723	65,900	65,038	64,851	66,021	64,843	64,406	63,730	61,616	61,489	60,720	59,752	58,014	58,429	58,703	58,378	57,480	54,220	50,241	47,558	45,497	0	0	0
OPERATING INCOME
29,498	27,542	32,699	33,960	36,231	34,074	31,584	33,281	28,850	35,358	37,382	37,470	46,907	47,877	51,378	55,744	56,401	56,977	56,060	54,767	53,501	53,435	52,392	53,695	56,262	55,849	57,314	56,095	53,008	52,582	49,296	47,094	44,613	40,748	40,033	38,664	38,309	36,472	41,138	45,188	0	0	0
OTHER INCOME (EXPENSE)
Interest income
462	643	681	694	609	495	418	340	282	221	171	127	98	72	67	47	31	34	23	28	27	27	25	21	28	41	44	53	55	44	42	72	84	103	115	104	107	110	124	144	0	0	0
Interest expense
2,534	2,349	1,945	1,529	1,456	1,488	1,520	1,553	1,585	1,614	1,642	1,665	1,301	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other, net
1,081	-729	122	-46	-163	117	-102	68	-85	463	518	615	682	-25	96	-291	-455	-342	-1,020	-696	-854	-671	-309	-726	-629	-344	4	299	490	190	378	299	304	465	352	512	467	459	138	112	0	0	0
Total other income (expense)
-991	-2,435	-1,142	-881	-1,010	-876	-1,204	-1,145	-1,388	-930	-953	-923	-905	-1,273	-734	-714	-467	-308	-997	-668	-827	-644	-284	-705	-601	-303	48	352	545	234	420	371	388	568	467	616	574	569	262	256	0	0	0
EARNINGS BEFORE INCOME TAXES
28,507	25,107	31,557	33,079	35,221	33,198	30,380	32,136	27,462	34,428	36,429	36,547	46,002	46,604	50,644	55,030	55,934	56,669	55,063	54,099	52,674	52,791	52,108	52,990	55,661	55,546	57,362	56,447	53,553	52,816	49,716	47,465	45,001	41,316	40,500	39,280	38,883	37,041	41,400	45,444	0	0	0
INCOME TAX PROVISION
7,139	6,004	7,175	7,366	7,762	7,545	6,531	7,995	9,906	12,848	14,872	15,225	16,166	16,989	18,415	19,825	20,381	20,137	19,523	18,844	17,686	17,573	17,365	17,279	18,626	18,562	19,330	18,992	17,663	17,549	16,345	15,957	15,251	13,932	13,669	13,837	13,852	13,290	14,753	15,617	0	0	0
NET EARNINGS
21,368	19,103	24,382	25,713	27,459	25,653	23,849	24,141	17,556	21,580	21,557	21,322	29,836	29,615	32,229	35,205	35,553	36,532	35,540	35,255	34,988	35,218	34,743	35,711	37,035	36,984	38,032	37,455	35,890	35,267	33,371	31,508	29,750	27,384	26,831	25,443	25,031	23,751	26,647	29,827	0	0	0
Earnings Per Share Data:
BASIC EARNINGS PER COMMON SHARE
0.22	0.07	0.09	0.12	0.17	0.19	0.13	0.16	0.12	0.15	0.13	0.01	0.22	0.15	0.13	0.21	0.22	0.21	0.20	0.22	0.24	0.19	0.20	0.21	0.25	0.18	0.21	0.25	0.25	0.21	0.21	0.21	0.23	0.16	0.16	0.17	0.18	0.15	0.13	0.16	0.15	0.22	0.21
DILUTED EARNINGS PER COMMON SHARE
0.22	0.07	0.09	0.12	0.17	0.19	0.13	0.16	0.12	0.15	0.13	0.01	0.22	0.15	0.13	0.21	0.21	0.21	0.20	0.22	0.24	0.19	0.20	0.21	0.24	0.18	0.23	0.24	0.24	0.20	0.20	0.21	0.23	0.16	0.15	0.17	0.18	0.15	0.12	0.16	0.15	0.22	0.21
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING -BASIC
42,830	42,789	42,703	42,639	42,496	42,446	42,365	42,349	42,323	42,263	42,188	42,203	42,202	42,159	41,964	42,076	42,053	41,947	41,608	41,714	41,707	41,607	41,463	41,478	41,471	41,408	41,186	41,304	41,266	41,148	41,082	41,091	41,080	41,067	40,822	40,737	40,686	40,615	40,515	40,535	40,514	40,496	40,500
EFFECT OF DILUTIVE STOCK OPTIONS AND RESTRICTED SHARE UNITS
138	149	132	271	450	459	499	409	409	399	400	390	366	376	393	387	372	380	358	379	341	334	-153	618	676	691	712	679	681	604	559	593	540	420	574	657	662	679	568	616	663	689	691
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED
42,968	42,938	42,835	42,910	42,946	42,905	42,864	42,758	42,732	42,662	42,588	42,593	42,568	42,535	42,357	42,463	42,425	42,327	41,966	42,093	42,048	41,941	41,310	42,096	42,147	42,099	41,898	41,983	41,947	41,752	41,641	41,684	41,620	41,487	41,396	41,394	41,348	41,294	41,083	41,151	41,177	41,185	41,191
ANTI-DILUTIVE SECURITIES:
Common share options and restricted share units
1,635	1,407	1,846	1,215	771	684	978	995	1,021	1,034	915	861	1,001	715	489	465	444	450	575	493	570	566	473	337	168	110	204	256	262	294	308	313	316	343	233	160	211	160	278	234	215	141	150
DIVIDENDS DECLARED PER COMMON SHARE
-	-	0.00	0.00	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.19	0.19	0.19	0.00	0.38	0.19	0.19	0.19	0.19	0.19	0.19	0.19	0.19	0.19	0.19	0.19	0.17	0.17